Tools to assess employment readiness for colorectal cancer survivors: A scoping review.
cancer
colorectal
employment
measurement
readiness
survivor
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
02
05
2023
accepted:
31
07
2023
medline:
28
9
2023
pubmed:
10
8
2023
entrez:
10
8
2023
Statut:
ppublish
Résumé
The ability to return to work and remain at work is an important recovery milestone after a cancer diagnosis. With the projected number of colorectal cancer patients of working age likely to increase, it is important to identify when a person is ready to resume work. There are many employment-related tools available to help people return to work after injury or illness; however, it is unknown which may be suitable for a person with colorectal cancer. To identify tools related to employment readiness in colorectal cancer survivors and to chart the relevant factors of employment assessed by these tools. Literature searches were performed in PubMed, CINAHL, Embase and Medline, the Cochrane library and PsycINFO using search terms around cancer, survivorship and employment to identify all peer-reviewed articles published in English up to June 2022. Thirty-five studies used a total of 77 tools focused on assessing employment issues experienced by people with cancer in general. Four tools were used with colorectal cancer survivors. None considered all relevant employment-related factors for colorectal cancer survivors. Tools used to identify return-to-work and remain-at-work were not specific to colorectal cancer. There are a range of existing tools that collate some, but not all, of the domains and outcome criteria required to meet the employment needs of colorectal cancer survivors. To optimize work outcomes for the working colorectal cancer population, a specified tool is warranted.
Sections du résumé
BACKGROUND
The ability to return to work and remain at work is an important recovery milestone after a cancer diagnosis. With the projected number of colorectal cancer patients of working age likely to increase, it is important to identify when a person is ready to resume work. There are many employment-related tools available to help people return to work after injury or illness; however, it is unknown which may be suitable for a person with colorectal cancer.
AIM
To identify tools related to employment readiness in colorectal cancer survivors and to chart the relevant factors of employment assessed by these tools.
METHOD
Literature searches were performed in PubMed, CINAHL, Embase and Medline, the Cochrane library and PsycINFO using search terms around cancer, survivorship and employment to identify all peer-reviewed articles published in English up to June 2022.
RESULTS
Thirty-five studies used a total of 77 tools focused on assessing employment issues experienced by people with cancer in general. Four tools were used with colorectal cancer survivors. None considered all relevant employment-related factors for colorectal cancer survivors.
CONCLUSION
Tools used to identify return-to-work and remain-at-work were not specific to colorectal cancer. There are a range of existing tools that collate some, but not all, of the domains and outcome criteria required to meet the employment needs of colorectal cancer survivors. To optimize work outcomes for the working colorectal cancer population, a specified tool is warranted.
Identifiants
pubmed: 37559402
doi: 10.1002/cam4.6432
pmc: PMC10523978
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18327-18353Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Colorectal Dis. 2014 Aug;16(8):O288-96
pubmed: 24428330
BMJ Open. 2015 Mar 24;5(3):e005971
pubmed: 25805526
BMC Public Health. 2016 Sep 06;15:940
pubmed: 27600542
J Rehabil Med. 2019 Mar 13;51(3):175-182
pubmed: 30768673
Cancer. 2016 Feb 1;122(3):438-46
pubmed: 26687819
J Cancer Surviv. 2016 Dec;10(6):1104-1111
pubmed: 27277896
Int J Mol Epidemiol Genet. 2016 Sep 30;7(3):105-114
pubmed: 27766137
Support Care Cancer. 2017 Apr;25(4):1087-1096
pubmed: 28013416
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Acta Oncol. 2016 Sep - Oct;55(9-10):1210-1219
pubmed: 27549145
J Cancer Surviv. 2015 Jun;9(2):349-60
pubmed: 25492237
Eur J Cancer. 2003 Jul;39(11):1562-7
pubmed: 12855263
Acta Oncol. 2015 May;54(5):743-9
pubmed: 25752974
Psychooncology. 2017 Sep;26(9):1354-1360
pubmed: 27862573
Intern Emerg Med. 2011 Dec;6(6):529-35
pubmed: 21512795
Epidemiol Prev. 2019 Mar-Jun;43(2-3):171-176
pubmed: 31293136
Acta Oncol. 2014 Jun;53(6):744-51
pubmed: 24195691
Iran J Public Health. 2014 Apr;43(4):391-405
pubmed: 28435811
J Occup Rehabil. 2018 Mar;28(1):97-106
pubmed: 28299536
J Occup Rehabil. 2018 Mar;28(1):170-179
pubmed: 28401441
Support Care Cancer. 2018 Aug;26(8):2815-2824
pubmed: 29511953
Psychometrika. 2018 Dec;83(4):991-1006
pubmed: 29611093
BMC Cancer. 2018 Dec 4;18(1):1207
pubmed: 30514325
J Cancer Surviv. 2010 Dec;4(4):415-37
pubmed: 20945110
J Cancer Surviv. 2014 Jun;8(2):173-82
pubmed: 24464639
Med Care. 2001 Jan;39(1):72-85
pubmed: 11176545
Environ Health Prev Med. 2017 Apr 04;22(1):23
pubmed: 29165171
Hong Kong J Occup Ther. 2016 Dec;28(1):15-23
pubmed: 30186063
Psychooncology. 2015 Apr;24(4):408-15
pubmed: 25174733
BMC Public Health. 2018 Jun 18;18(1):756
pubmed: 29914463
J Cancer Surviv. 2017 Dec;11(6):791-799
pubmed: 28470507
Int J Cancer. 2017 Nov 1;141(9):1751-1762
pubmed: 28681478
Colorectal Dis. 2016 Jan;18(1):59-66
pubmed: 26391723
Brain Inj. 2018;32(13-14):1731-1739
pubmed: 30296173
Health Qual Life Outcomes. 2017 Sep 19;15(1):180
pubmed: 28927453
J Occup Rehabil. 2005 Dec;15(4):453-7
pubmed: 16254748
J Eval Clin Pract. 2018 Jun;24(3):459-467
pubmed: 29464873
Acta Oncol. 2017 Feb;56(2):174-182
pubmed: 28093023
Support Care Cancer. 2019 Feb;27(2):539-546
pubmed: 30014191
J Clin Oncol. 2014 Jul 1;32(19):2025-30
pubmed: 24888800
Asian Pac J Cancer Prev. 2015;16(6):2257-61
pubmed: 25824747
Psychooncology. 2013 Jun;22(6):1208-19
pubmed: 22888070
Crit Rev Oncol Hematol. 2011 Feb;77(2):109-30
pubmed: 20117019
Psychooncology. 2018 Apr;27(4):1206-1212
pubmed: 29370448
Int J Environ Res Public Health. 2018 Mar 16;15(3):
pubmed: 29547510
Qual Life Res. 2016 Apr;25(4):997-1005
pubmed: 26395276
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
BMC Cancer. 2018 Jul 20;18(1):751
pubmed: 30029637
Palliat Support Care. 2018 Jun;16(3):347-364
pubmed: 29262876
J Prev Med Public Health. 2015 Jul;48(4):180-7
pubmed: 26265663
BMC Cancer. 2016 May 10;16:303
pubmed: 27165185
Eur J Cancer Care (Engl). 2015 Nov;24(6):765-7
pubmed: 26492338
BMJ Open. 2017 Jun 15;7(6):e014746
pubmed: 28619770
Eur J Cancer Care (Engl). 2021 Jul;30(4):e13421
pubmed: 33733545
Support Care Cancer. 2016 Jul;24(7):3175-84
pubmed: 26935051
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12690
pubmed: 28440572
Perm J. 2017;22:17-022
pubmed: 29236653
Cancer Med. 2023 Sep;12(17):18327-18353
pubmed: 37559402
Psychooncology. 2016 Jul;25(7):873-6
pubmed: 26315583
Disabil Rehabil. 2014;36(11):914-24
pubmed: 23962195
Head Neck. 2017 May;39(5):893-899
pubmed: 28170129
BMC Public Health. 2014 Sep 17;14:963
pubmed: 25230842
Eur J Pediatr. 2018 Nov;177(11):1641-1652
pubmed: 30091109
Head Neck. 2015 Apr;37(4):585-93
pubmed: 24677561
Disabil Rehabil. 2017 Oct;39(21):2164-2172
pubmed: 27596990